Read More

ATEC Announces Preliminary Revenue Results For 2023 And 2024 Revenue Guidance; Sees Q4 Revenue $136.8M-$138.4M Vs $128.19M Est.; Sees FY23 Revenue Over $480M Vs $472.48M Est.; FY24 Revenue $595M Vs $566.5M Est.

Full-year 2023 total revenue grew approximately 37% to over $480 millionExpected full-year 2024 total revenue of $595 millionAlphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to

ATEC

Read More

Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue And Provides Corporate Updates; Sees Q4 Revenue $69M-$71M Vs $68.27M Est.; FY23 Revenue $178M-$180M Vs $185.4M Est.; LIVMARLI Net Products Sales Of $141M-143M Expected For 2023

- $186-188 million in total revenue and $178-180 million net product sales expected for 2023, preliminary and unaudited- LIVMARLI net products sales of $141-143 million expected for 2023, representing approximately 89%

MIRM

Read More

Newell Brands Announces Organizational Realignment; Plans To Reduce Its Office Roles By ~7%, With Most Of These Actions Expected To Be Complete By The End Of 2024; Expect Annualized Pre-tax Savings Of $65M-$90M, Net Of Reinvestment

Plan to Accelerate Where to Play / How to Win Strategy Choices and Reduce Overhead CostExpect Annualized Pre-Tax Savings of $65 Million to $90 Million, Net of ReinvestmentNewell Brands (NASDAQ:NWL) today announced an

NWL